A Closer Look

Medicare Therapy Caps: What's Next?

This year, we got closer than we ever have before to permanently repealing the Medicare therapy caps, but we still have more work to do. Learn more.

Telehealth and Medical Research Events in DC

PAN, our advocates, and our partners will be participating in two events next week: National Health IT Week and the Rally for Medical Research. Learn more.

Illinois State Director Speaks at 21st Century Cures Roundtable

On Sept. 5, Illinois State Director Roger Halleen participated in a 21st Century Cures roundtable hosted by Rep. John Shimkus (R-IL) and Rep. Rodney Davis (R-IL) in Springfield, Illinois. Learn more.

Watch the Fall of Appropriations Webinar

On Sept. 8, PAN hosted a webinar on the federal funding process titled, Fall of Appropriations. You may now view the full presentation here. Learn more.

Tell Congress to Support Research

Congress has returned from August recess with few scheduled legislative days to tackle a number of priorities, including federal appropriations for Fiscal Year (FY) 2015, before adjourning again for the election recess. Learn more.

PAN Submits Two Comment Letters to CMS

In response to proposed rules released in July, PAN submitted two comment letters to the Centers for Medicare and Medicaid Services (CMS) on access to and payment of various services by physicians and hospitals. Learn more.

World Parkinson Coalition to Hold Online Conference

The World Parkinson Coalition (WPC) is hosting its first ever WPC Scientific Update online for free September 30 to October 1. Learn more.

Carnegie Mellon University Creates New Brain Initiative

Carnegie Mellon University (CMU) has launched the CMU BrainHub℠ to learn more about the structure and activity of the brain. Learn more.

PhRMA Launches New Website on Biopharmaceutical Innovation

The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched Innovation Hub at www.innovation.org, which provides PhRMA resources related to the research and development process, the biopharmaceutical pipeline, and progress fighting various diseases. Learn more.

News on Parkinson's Drugs

Pharmaceutical companies, Lundbeck and ACADIA, announced advancements in getting new drugs that treat people with Parkinson’s on the market, while Teva announced a recall affecting a generic Parkinson’s drug. Learn more.